Conversion Surgery for Patients with Advanced Gastric Cancer with Peritoneal Carcinomatosis

Table 2

Surgical and postoperative characteristics in the conversion group and CRS + HIPEC group.

Variable		Conversion surgery	CRS + HIPEC
		(n = 34)	(n = 15)
PCI score		17.44 ± 8.9	7.46 ± 5.3
Mean visceral resection (range)		2.87 (1–4)	2.28 (1–4)	0.882
Completeness of cytoreduction	CC-0 (%)	26 (76.7)	11 (73.3)	0.794
	CC-1 (%)	7 (20.4)	3 (25.0)
	CC-2 (%)	1 (2.9)	1 (6.7)
Operation time (min)		472.3 ± 165.3	490.3 ± 54.2	0.391
Blood loss (ml)		228.3 ± 108.8	285.7 ± 105.5	0.168
Complications	Bleeding (%)	1 (3.0)	1 (7.1)	0.556
	Anastomotic leakage (%)	5 (15.2)	2 (14.3)	0.996
	Infection (%)	4 (12.1)	1 (7.1)	0.802
	Total (%)	10 (29.4)	4 (26.7)	0.894
	1-year surgical mortality	80.0% (8/10)	75% (3/4)	0.982

CRS + HIPEC: cytoreductive surgery + hyperthermic intraperitoneal chemotherapy; CC: complete cytoreduction score; PCI: peritoneal cancer index.